Chad Therapeutics Reports Loss

Chad Therapeutics Inc., Chatsworth, posted a net loss for the second quarter ended Sept. 30 of $434,000 compared to net income of $2,000 for the same period in 1998. Revenues fell to $3.4 million from $3.9 million.

Chad Therapeutics produces and develops oxygen systems and conserving devices for medical use.